Ovarian Cancer: Multi-Omics Data Integration

被引:1
作者
Kliuchnikova, Anna [1 ]
Gordeeva, Arina [1 ]
Abdurakhimov, Aziz [1 ]
Materova, Tatiana [1 ]
Tarbeeva, Svetlana [1 ]
Sarygina, Elizaveta [1 ]
Kozlova, Anna [1 ]
Kiseleva, Olga [1 ]
Ponomarenko, Elena [1 ]
Ilgisonis, Ekaterina [1 ]
机构
[1] Inst Biomed Chem, Moscow 119121, Russia
基金
俄罗斯科学基金会;
关键词
ovarian carcinoma; molecular heterogeneity; multi-omics; personalized therapy; biomarkers; omics; DEPLETED PLASMA; LIVER-TISSUE; EXPRESSION; MUTATIONS; CARCINOMA; SURVIVAL; BREAST; BRCA2; CELLS; WOMEN;
D O I
10.3390/ijms26135961
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This study focuses on the systematization and integration of ovarian cancer multi-omics data, revealing patterns in the application of different omics-based approaches and assessing factors that affect the identification of potential biomarkers. An integrative analysis of 51 publications revealed 1649 potential biomarkers. The findings emphasized the molecular diversity of ovarian cancer. They demonstrated the importance of performing the comprehensive integration of molecular and clinical data to search for diagnostic alternatives and molecular patterns underlying ovarian cancer. The heterogeneity of data sources, differences in data acquisition and analysis protocols, and the lack of uniform standards affect the reproducibility of the results of genomic and post-genomic profiling. Multi-omics studies are more promising than mono-omics-based ones. Despite technological advances, researchers continue to focus on results obtained over a decade ago, which may hinder the scientific community from exploring new horizons in ovarian cancer research.
引用
收藏
页数:18
相关论文
共 71 条
[61]   Genomic instability in breast and ovarian cancers: translation into clinical predictive biomarkers [J].
Vollebergh, Marieke A. ;
Jonkers, Jos ;
Linn, Sabine C. .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2012, 69 (02) :223-245
[62]   Investigation of the mechanism by which FOXJ2 inhibits proliferation, metastasis and cell cycle progression of ovarian cancer cells through the PI3K/AKT signaling pathway [J].
Wang, Liyuan ;
He, Han ;
Zhai, Ruifang ;
Gao, Ruifan ;
Su, Min ;
Duan, Ruiyun ;
Tu, Zengrong ;
Huang, Rong .
EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2025, 30 (01) :152
[63]   Advances in artificial intelligence for the diagnosis and treatment of ovarian cancer (Review) [J].
Wang, Yanli ;
Lin, Weihong ;
Zhuang, Xiaoling ;
Wang, Xiali ;
He, Yifang ;
Li, Luhong ;
Lyu, Guorong .
ONCOLOGY REPORTS, 2024, 51 (03)
[64]   Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers [J].
Wang, Yuxuan ;
Li, Lu ;
Douville, Christopher ;
Cohen, Joshua D. ;
Yen, Ting-Tai ;
Kinde, Isaac ;
Sundfelt, Karin ;
Kjaer, Susanne K. ;
Hruban, Ralph H. ;
Shih, Ie-Ming ;
Wang, Tian-Li ;
Kurman, Robert J. ;
Springer, Simeon ;
Ptak, Janine ;
Popoli, Maria ;
Schaefer, Joy ;
Silliman, Natalie ;
Dobbyn, Lisa ;
Tanner, Edward J. ;
Angarita, Ana ;
Lycke, Maria ;
Jochumsen, Kirsten ;
Afsari, Bahman ;
Danilova, Ludmila ;
Levine, Douglas A. ;
Jardon, Kris ;
Zeng, Xing ;
Arseneau, Jocelyne ;
Fu, Lili ;
Diaz, Luis A., Jr. ;
Karchin, Rachel ;
Tomasetti, Cristian ;
Kinzler, Kenneth W. ;
Vogelstein, Bert ;
Fader, Amanda N. ;
Gilbert, Lucy ;
Papadopoulos, Nickolas .
SCIENCE TRANSLATIONAL MEDICINE, 2018, 10 (433)
[65]   RB1 Is an Immune-Related Prognostic Biomarker for Ovarian Cancer [J].
Xie, Biao ;
Tan, Guangqing ;
Ren, Jingyi ;
Lu, Weiyu ;
Pervaz, Sadaf ;
Ren, Xinyi ;
Otoo, Antonia Adwoa ;
Tang, Jing ;
Li, Fangfang ;
Wang, Yingxiong ;
Wang, Meijiao .
FRONTIERS IN ONCOLOGY, 2022, 12
[66]   Subtype-GAN: a deep learning approach for integrative cancer subtyping of multi-omics data [J].
Yang, Hai ;
Chen, Rui ;
Li, Dongdong ;
Wang, Zhe .
BIOINFORMATICS, 2021, 37 (16) :2231-2237
[67]   Applications of Multi-omics Approaches for Exploring the Molecular Mechanism of Ovarian Carcinogenesis [J].
Ye, Miaomiao ;
Lin, Yibin ;
Pan, Shuya ;
Wang, Zhi-wei ;
Zhu, Xueqiong .
FRONTIERS IN ONCOLOGY, 2021, 11
[68]   Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 [J].
Zeng, Mei ;
Kwiatkowski, Nicholas P. ;
Zhang, Tinghu ;
Nabet, Behnam ;
Xu, Mousheng ;
Liang, Yanke ;
Quan, Chunshan ;
Wang, Jinhua ;
Hao, Mingfeng ;
Palakurthi, Sangeetha ;
Zhou, Shan ;
Zeng, Qing ;
Kirschmeier, Paul T. ;
Meghani, Khyati ;
Leggett, Alan L. ;
Qi, Jun ;
Shapiro, Geoffrey I. ;
Liu, Joyce F. ;
Matulonis, Ursula A. ;
Lin, Charles Y. ;
Konstantinopoulos, Panagiotis A. ;
Gray, Nathanael S. .
ELIFE, 2018, 7
[69]   Chromosome 18 Transcriptome Profiling and Targeted Proteome Mapping in Depleted Plasma, Liver Tissue and HepG2 Cells [J].
Zgoda, Victor G. ;
Kopylov, Arthur T. ;
Tikhonova, Olga V. ;
Moisa, Alexander A. ;
Pyndyk, Nadezhda V. ;
Farafonova, Tatyana E. ;
Novikova, Svetlana E. ;
Lisitsa, Andrey V. ;
Ponomarenko, Elena A. ;
Poverennaya, Ekaterina V. ;
Radko, Sergey P. ;
Khmeleva, Svetlana A. ;
Kurbatov, Leonid K. ;
Filimonov, Aleksey D. ;
Bogolyubova, Nadezhda A. ;
Ilgisonis, Ekaterina V. ;
Chernobrovkin, Aleksey L. ;
Ivanov, Alexis S. ;
Medvedev, Alexei E. ;
Mezentsev, Yury V. ;
Moshkovskii, Sergei A. ;
Naryzhny, Stanislav N. ;
Ilina, Elena N. ;
Kostrjukova, Elena S. ;
Alexeev, Dmitry G. ;
Tyakht, Alexander V. ;
Govorun, Vadim M. ;
Archakov, Alexander I. .
JOURNAL OF PROTEOME RESEARCH, 2013, 12 (01) :123-134
[70]   Targeting IκB Kinase β/NF-κB Signaling in Human Prostate Cancer by a Novel IκB Kinase β Inhibitor CmpdA [J].
Zhang, Yanting ;
Lapidus, Rena G. ;
Liu, Peiyan ;
Choi, Eun Yong ;
Adediran, Samusi ;
Hussain, Arif ;
Wang, Xinghuan ;
Liu, Xuefeng ;
Dan, Han C. .
MOLECULAR CANCER THERAPEUTICS, 2016, 15 (07) :1504-1514